Objectives

1. Treatment of Pseudomonas aeruginosa

2. Treatment of multi-drug resistant (MDR) Acinetobacter

3. Treatment of AmpC, extended- spectrum betalactamase (ESBL), and carbapenemase producing Enterbacteriaceae.

Session date: 
Monday, October 7, 2019 - 12:00pm to 1:00pm
Location: 
UCMC C-400
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.